ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

LIFE aTyr Pharma Inc

1.59
0.02 (1.27%)
2024年5月2日 - 終了
15分遅延
名称 銘柄コード 市場 種別
aTyr Pharma Inc LIFE NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.02 1.27% 1.59 08:50:42
始値 安値 高値 終値 前日終値
1.56 1.56 1.61 1.59 1.57
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0121:00GLOBEaTyr Pharma to Participate in April Investor Conferences
2024/3/1505:00GLOBEaTyr Pharma Announces Fourth Quarter and Full Year 2023..
2024/2/2822:00GLOBEaTyr Pharma to Webcast Conference Call Reporting Fourth..
2024/2/2122:00GLOBEaTyr Pharma Announces Expanded Access Program (EAP) for..
2024/2/0710:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0710:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2922:00GLOBEaTyr Pharma to Present Posters Highlighting Importance of..
2024/1/1822:00GLOBEaTyr Pharma Announces Howard University President Emeritus..
2024/1/1009:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1009:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0302:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/1308:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2114:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/1406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1322:00GLOBEaTyr Pharma Presents Poster Demonstrating Preclinical..
2023/11/1007:01EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1006:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/1006:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:06EDGAR2Form 8-K - Current report
2023/11/1006:00GLOBEaTyr Pharma Announces Third Quarter 2023 Results and..
2023/11/0121:00GLOBEaTyr Pharma to Present at November Investor Conferences
2023/10/3121:00GLOBEaTyr Pharma Announces Dosing of First Patient in Phase 2..
2023/9/2622:01EDGAR2Form 8-K - Current report
2023/9/1121:04EDGAR2Form 8-K - Current report
2023/9/1121:00GLOBEaTyr Pharma Presents Efzofitimod Data Demonstrating..
2023/8/2421:00GLOBEaTyr Pharma to Present at the H.C. Wainwright 25th Annual..
2023/8/1105:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/1005:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1005:10EDGAR2Form 8-K - Current report
2023/8/1005:00GLOBEaTyr Pharma Announces Second Quarter 2023 Results and..
2023/8/0205:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2221:00GLOBEEuropean Commission Grants Orphan Drug Designation for aTyr..
2023/6/2021:00GLOBEaTyr Pharma to Present on Lead Therapeutic Candidate..
2023/6/1005:00GLOBEaTyr Pharma Announces Inducement Grants Under Nasdaq Listing..
2023/6/0621:00GLOBEaTyr Pharma to Highlight Advancements in tRNA Synthetase..
2023/5/2521:00GLOBEaTyr Pharma to Present at the 2023 Jefferies Healthcare..
2023/5/2221:00GLOBEaTyr Pharma Presents New Data on Efzofitimod Mechanism of..
2023/5/1205:00GLOBEaTyr Pharma to Present at the 2023 RBC Capital Markets..
2023/5/1005:00GLOBEaTyr Pharma Announces First Quarter 2023 Results and..

最近閲覧した銘柄

Delayed Upgrade Clock